✦ LIBER ✦

35 Second line chemotherapy with cisplatin (C) plus paclitaxel (P) for chemo refractory and resistant small cell lung cancer (SCLC) patients (pts)

✍ Scribed by Barradas, Pedro S.; Lopes, Adelia M.; Costa, Agostinho S.; Cristovao, Margarida M.; Alves, Ana P.; Melo, Maria-Jose S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel (P) and c

✍ Agelaki, S.; Agelidou, M.; Blazogiannakis, G.; Tsiafaki, X.; Palamidas, Th.; Kou 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Cisplatin and vinorelbine as second-line

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

EORTC LCCG Phase II study of topotecan i

✍ Ardizzoni, A; Manegold, C; Debruyne, C; Gaafar, R; Buchholz, E; Dussenne, S; Leg 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Irinotecan plus gemcitabine vs irinoteca

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

P-531 Phase II study of sequential gemci

✍ Chiappori, Alberto; Simon, George; Lima, Caio Rocha; Williams, Charles; Haura, E 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 360 KB

PCN43 THE COST OF TREATING GRADE 3/4 ADV

✍ C Chouaid; A Vergnenegre; M Brunner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB